Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms
- 1 October 2010
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 45 (3) , 181-185
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Leukaemogenesis: more than mutant genesNature Reviews Cancer, 2010
- Aberrant DNA methylation is a dominant mechanism in MDS progression to AMLBlood, 2009
- Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid LeukemiasCurrent Medicinal Chemistry, 2008
- The human promoter methylomeNature Genetics, 2007
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemiaAmerican Journal of Hematology, 2004
- Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromesBlood, 2004
- Methylation profiling in acute myeloid leukemiaBlood, 2001
- Hypermethylation of E-cadherin in leukemiaBlood, 2000
- Regulation of Cadherin Adhesive ActivityJournal of Cell Biology, 2000